☆ 4.3 Review

Levetiracetam, from broad-spectrum use to precision prescription: A narrative review and expert opinion

SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2023)

Related references

Note: Only part of the references are listed.

Review Clinical Neurology

Visually sensitive seizures: An updated review by the Epilepsy Foundation

Robert S. Fisher et al.

Summary: Light stimulation can trigger seizures in certain individuals, especially in young people and those with specific forms of epilepsy. Photosensitive seizures can coexist with spontaneous seizures and have a genetic component. The exact mechanisms of photosensitive seizures are still unclear, but specific triggers such as flashes or color changes can provoke seizures. Prevention strategies include avoiding triggers, covering one eye, keeping a safe distance from screens, reducing contrast, and taking certain antiseizure medications. Visually-induced seizures pose significant public health risks, requiring ongoing scientific research, regulation, and public education.

EPILEPSIA (2022)

Add to Collection

Article Clinical Neurology

Efficacy of levetiracetam in STXBP1 encephalopathy with different phenotypic and genetic spectra

Qiu-Hong Wang et al.

Summary: This study analyzed the prognosis of Levetiracetam (LEV) treatment for STXBP1 encephalopathy and explored the correlation among genotype, phenotype, and LEV efficacy. The results showed that LEV could improve the partial remission rate in patients with STXBP1 encephalopathy, but did not achieve seizure freedom. LEV combined with other anti-seizure medications could increase the seizure remission rate, especially for refractory types of epilepsy.

SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2022)

Add to Collection

Editorial Material Clinical Neurology

SANAD II: Dear Levetiracetam, the Honeymoon Is Over

Adriana Bermeo-Ovalle

EPILEPSY CURRENTS (2022)

Add to Collection

Article Clinical Neurology

Antiseizure Medication Concentrations During Pregnancy Results From the Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs (MONEAD) Study

Page B. Pennell et al.

Summary: This study aims to characterize the changes in concentration of antiseizure medications during pregnancy. The results show that dose-normalized concentrations during pregnancy are significantly decreased compared to postpartum values, suggesting the need for increasing doses of these medications throughout pregnancy.

JAMA NEUROLOGY (2022)

Add to Collection

Review Clinical Neurology

Epilepsy Genetics and Precision Medicine in Adults: A New Landscape for Developmental and Epileptic Encephalopathies

Alvaro Beltran-Corbellini et al.

Summary: This review focuses on epilepsy genetics and precision medicine in adult patients, particularly developmental and epileptic encephalopathies (DEEs). It discusses issues such as candidate selection for genetic testing, genetic test options, and interpretation. DEEs are clinically heterogeneous syndromes with challenges in diagnosis and treatment. Recent studies suggest that individuals with epilepsy and various risk factors are suitable candidates for genetic testing. An accurate diagnosis is crucial for precision medicine.

FRONTIERS IN NEUROLOGY (2022)

Add to Collection

Editorial Material Clinical Neurology

Challenge to levetiracetam's de facto position as generic first-line antiseizure medication

Aidan Neligan et al.

PRACTICAL NEUROLOGY (2022)

Add to Collection

Article Neurosciences

Efficacy comparison of oxcarbazepine and levetiracetam monotherapy among patients with newly diagnosed focal epilepsy in China: A multicenter, open-label, randomized study

Haoyue Zhu et al.

Summary: This study compared the efficacy and effects of oxcarbazepine and levetiracetam as monotherapies for patients with newly diagnosed focal epilepsy in China. The results showed that oxcarbazepine monotherapy may be more effective than levetiracetam monotherapy, and both drugs improved the quality of life and anxiety state of the patients.

CNS NEUROSCIENCE & THERAPEUTICS (2022)

Add to Collection

Article Clinical Neurology

International League Against Epilepsy classification and definition of epilepsy syndromes with onset in childhood: Position paper by the ILAE Task Force on Nosology and Definitions

Nicola Specchio et al.

Summary: The 2017 International League Against Epilepsy classification defines a three-tier system for epilepsy syndromes, with childhood onset epilepsy syndromes falling into three categories: self-limited focal epilepsies, generalized epilepsies, and developmental and/or epileptic encephalopathies. Identification of specific syndromes helps guide management and prognosis. This paper describes these childhood onset epilepsy syndromes, highlighting their seizure types, EEG features, phenotypic variations, and key investigation findings.

EPILEPSIA (2022)

Add to Collection

Article Clinical Neurology

A pharmacogenomic assessment of psychiatric adverse drug reactions to levetiracetam

Ciaran Campbell et al.

Summary: This study aimed to determine the contribution of genetic variation to psychiatric and behavioral adverse drug reactions associated with levetiracetam. The results showed that a polygenic burden for schizophrenia is a risk factor for levetiracetam-associated psychotic reaction, but no evidence of an increased burden of rare genetic variants was found.

EPILEPSIA (2022)

Add to Collection

Article Behavioral Sciences

Trends in antiseizure medication prescription patterns among all adults, women, and older adults with epilepsy: A German longitudinal analysis from 2008 to 2020

Maja Hochbaum et al.

Summary: This study analyzed the patterns of antiseizure medication prescriptions among adult epilepsy patients and found an increasing trend in the prescription of third-generation drugs. The use of first- and second-generation drugs decreased, and enzyme-inducing drugs were used less frequently. Among women of childbearing potential, prescriptions were adjusted to minimize the risk of birth defects. Older adults showed a decrease in the use of carbamazepine to avoid hyponatremia risks and drug interactions. Levetiracetam was commonly used as a monotherapy for patients with genetic generalized epilepsy.

EPILEPSY & BEHAVIOR (2022)

Add to Collection

Review Critical Care Medicine

Levetiracetam for Seizure Prophylaxis in Neurocritical Care: A Systematic Review and Meta-analysis

Taolin Fang et al.

Summary: Based on current data with moderate to high risk of bias, the use of levetiracetam prophylaxis for seizure prevention in TBI, SAH, and ICH did not show significant reductions in seizure incidence. However, it may be beneficial for patients after supratentorial neurosurgery. More high-quality randomized trials are needed to further evaluate the prophylactic use of levetiracetam.

NEUROCRITICAL CARE (2022)

Add to Collection

Review Clinical Neurology

Concentrations of antiseizure medications in breast milk of lactating women with epilepsy: A systematic review with qualitative synthesis

Ramzi Shawahna et al.

Summary: This systematic review evaluated the concentrations of antiseizure medications (ASMs) in the breastmilk of women with epilepsy (WWE) and assessed the potential risks to infants. The results revealed that some ASMs had high relative infant doses, which could have adverse effects on infants. Therefore, close monitoring of infants' conditions and consideration of reducing or discontinuing breastfeeding should be applied during lactation.

SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2022)

Add to Collection

Article Clinical Neurology

2022 Guideline for the Management of Patients With Spontaneous Intracerebral Hemorrhage: A Guideline From the American Heart Association/American Stroke Association

Steven M. Greenberg et al.

STROKE (2022)

Add to Collection

Review Clinical Neurology

Synaptopathies in Developmental and Epileptic Encephalopathies: A Focus on Pre-synaptic Dysfunction

Giulia Spoto et al.

Summary: The proper connection between pre- and post-synaptic nervous cells relies on various components including membranes, the synaptic cleft, glial cells, and extracellular matrix. Synaptopathy refers to the alteration of mechanisms regulating these synaptic components and is associated with neuropsychiatric disorders. Developmental and Epileptic Encephalopathies (DEEs) are a group of epilepsy syndromes associated with cognitive disturbances, intellectual disability, autistic features, and movement disorders. This review focuses on the pathogenesis of DEEs, particularly on the role of pre-synaptic terminals and potential therapeutic approaches.

FRONTIERS IN NEUROLOGY (2022)

Add to Collection

Review Chemistry, Medicinal

Levetiracetam Mechanisms of Action: From Molecules to Systems

Itzel Jatziri Contreras-Garcia et al.

Summary: This study provides a comprehensive review of levetiracetam, discussing its clinical uses, structural properties, therapeutic targets, and various molecular, genetic, and systemic action mechanisms, highlighting its potential as a candidate for drug repurposing.

PHARMACEUTICALS (2022)

Add to Collection

Article Clinical Neurology

Efficacy and safety of antiseizure medication in post-stroke epilepsy

Yaroslav Winter et al.

Summary: Antiseizure medications acting through the slow inactivation of sodium channels, such as lacosamide and eslicarbazepine, show better tolerance and may be associated with improved seizure control in post-stroke epilepsy.

SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2022)

Add to Collection

Article Genetics & Heredity

Efficacy, Tolerability, and Retention of Antiseizure Medications in PRRT2-Associated Infantile Epilepsy

Jan H. Doring et al.

Summary: In this study, the treatment response of antiseizure medications (ASMs) in children with PRRT2-associated infantile epilepsy was evaluated. It was found that sodium channel blockers such as carbamezepine and OXC were effective, while LEV showed lower efficacy. All ASMs reported in the cohort had good tolerability in these young children.

NEUROLOGY-GENETICS (2022)

Add to Collection

Article Clinical Neurology

Antiseizure medication for brain metastasis-related epilepsy: Findings of optimal choice from a retrospective cohort

Angel Aledo-Serrano et al.

Summary: The study found that levetiracetam is the most commonly used antiseizure medication in patients with brain metastasis-related epilepsy treated with radiosurgery, but common psychiatric comorbidities in this population may influence the choice of medication.

EPILEPSY RESEARCH (2021)

Add to Collection

Article Behavioral Sciences

Differences in levetiracetam and perampanel treatment-related irritability in patients with epilepsy

Naoya Hasegawa et al.

Summary: The study evaluated irritability as a side effect in epilepsy patients receiving both levetiracetam (LEV) and perampanel (PER) therapy, finding that LEV and PER caused irritability in different patient groups. Irritability was associated with EEG findings of temporal focal epileptic discharge and higher dosages of LEV for LEV-related irritability, as well as with psychiatric comorbidity of irritability and EEG findings of nontemporal focal epileptic discharge for PER-related irritability.

EPILEPSY & BEHAVIOR (2021)

Add to Collection

Review Clinical Neurology

Alternatives to valproate in girls and women of childbearing potential with Idiopathic Generalized Epilepsies: state of the art and guidance for the clinician proposed by the Epilepsy and Gender Commission of the Italian League Against Epilepsy (LICE)

Barbara Mostacci et al.

Summary: In response to recent restrictions on valproate use in females of childbearing potential, the Italian League against Epilepsy's Commission on Epilepsy and Gender synthesized current literature and legislative data to guide clinicians on antiseizure medication prescription for Idiopathic Generalized Epilepsies, recommending alternatives to valproate. The review highlighted first-choice drugs such as levetiracetam and lamotrigine in specific epilepsy syndromes, while also addressing off-label use, contraindications, and discrepancies in warnings among different brands of the same active ingredient. Recommendations include the need for revised prescription rules consistent with latest literature data and uniformity in warnings for the same active ingredients.

SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2021)

Add to Collection

Article Clinical Neurology

Effect of Levetiracetam on Cognition in Patients With Alzheimer Disease With and Without Epileptiform Activity A Randomized Clinical Trial

Keith Vossel et al.

Summary: The study demonstrated that treatment with levetiracetam improved spatial memory and executive function tasks in patients with Alzheimer's disease and epileptiform activity, suggesting the need for further assessment of antiseizure approaches in AD.

JAMA NEUROLOGY (2021)

Add to Collection

Article Medicine, General & Internal

The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial

Anthony Marson et al.

LANCET (2021)

Add to Collection

Article Medicine, General & Internal

The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial

Anthony Marson et al.

LANCET (2021)

Add to Collection

Review Clinical Neurology

Uncommon epileptic syndromes in children: a review

Josefina de la Jara et al.

Summary: Epileptic syndromes are well-defined conditions with specific clinical features and EEG changes, essential for pediatric neurology practice. However, many of these syndromes are unfamiliar to medical professionals due to their low incidence and limited literature representation.

SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2021)

Add to Collection

Article Clinical Neurology

Etiology-specific response to antiseizure medication in focal epilepsy

Jakob I. Doerrfuss et al.

Summary: In focal epilepsy, the response to treatment with ASM is highly dependent on the underlying etiology, with patients whose epilepsy is due to ischemic stroke having the best treatment outcome. Interestingly, patients with the lowest ASM load also achieved the most favorable seizure outcomes among all etiological groups.

EPILEPSIA (2021)

Add to Collection

Article Medicine, Research & Experimental

An Investigation of Levetiracetam in Alzheimer's Disease (ILiAD): a double-blind, placebo-controlled, randomised crossover proof of concept study

Arjune Sen et al.

Summary: This study investigates whether the anti-seizure medication levetiracetam can help cognitive function in patients with dementia, showing potential therapeutic benefits.

TRIALS (2021)

Add to Collection

Article Clinical Neurology

Anti-seizure Medication Prescription in Adult Outpatients With Epilepsy in China, 2013-2018

Lingyan Yu et al.

Summary: The study found that from 2013 to 2018, there was a rapid increase in the number and cost of anti-seizure medication prescriptions for Chinese adult outpatients with epilepsy. The use of newer anti-seizure medications increased, with sodium valproate use decreasing and levetiracetam use dramatically increasing. Monotherapy was more common than combination therapy.

FRONTIERS IN NEUROLOGY (2021)

Add to Collection

Review Medicine, General & Internal

Epilepsy in Down Syndrome: A Highly Prevalent Comorbidity

Miren Altuna et al.

Summary: Individuals with Down syndrome have an increased risk of epilepsy, especially in late middle age, which is linked to the development of Alzheimer's disease. Increased awareness and understanding of epilepsy in this population could lead to earlier diagnoses and improved treatments.

JOURNAL OF CLINICAL MEDICINE (2021)

Add to Collection

Article Clinical Neurology

Response to antiseizure medications in epileptic patients with malformation of cortical development

Wei Chen et al.

Summary: This study investigated the treatment outcomes and predictors for seizure freedom in epileptic patients with MCD undergoing ASM regimens. The findings suggest that medical treatment can be successful in a minority of epileptic patients with MCD, and pretreatment seizure frequency is a predictor of treatment outcome. Additionally, sodium channel blockers monotherapy showed higher efficacy in achieving seizure freedom in the initial ASM regimen.

THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2021)

Add to Collection

Article Clinical Neurology

A multi-disciplinary clinic for SCN8A-related epilepsy

John M. Schreiber et al.

EPILEPSY RESEARCH (2020)

Add to Collection

Article Clinical Neurology

Levetiracetam efficacy in PCDH19 Girls Clustering Epilepsy

Lynette G. Sadleir et al.

EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY (2020)

Add to Collection

Review Clinical Neurology

Clinical and experimental insight into pathophysiology, comorbidity and therapy of absence seizures

Vincenzo Crunelli et al.

BRAIN (2020)

Add to Collection

Article Medicine, General & Internal

Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trial

James M. Chamberlain et al.

LANCET (2020)

Add to Collection

Article Clinical Neurology

Rapidity of CNS Effect on Photoparoxysmal Response for Brivaracetam vs. Levetiracetam: A Randomized, Double-blind, Crossover Trial in Photosensitive Epilepsy Patients

Ronald C. Reed et al.

CNS DRUGS (2020)

Add to Collection

Article Clinical Neurology

Antiseizure medication withdrawal in seizure-free patients with PCDH19-related epilepsy: A multinational cohort survey

Angel Aledo-Serrano et al.

SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2020)

Add to Collection

Article Clinical Neurology

Pharmacologic treatment and SUDEP risk A nationwide, population-based, case-control study

Olafur Sveinsson et al.

NEUROLOGY (2020)

Add to Collection

Article Clinical Neurology

Cerebrovascular disease burden in late-onset non-lesional focal epilepsy

Laura Abraira et al.

SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2019)

Add to Collection

Article Clinical Neurology

Prediction Tools for Psychiatric Adverse Effects After Levetiracetam Prescription

Colin B. Josephson et al.

JAMA NEUROLOGY (2019)

Add to Collection

Article Medicine, General & Internal

Levetiracetam versus phenytoin for second-line treatment of convulsive status epilepticus in children (ConSEPT): an open-label, multicentre, randomised controlled trial

Stuart R. Dalziel et al.

LANCET (2019)

Add to Collection

Article Medicine, General & Internal

Levetiracetam versus phenytoin for second-line treatment of paediatric convulsive status epilepticus (EcLiPSE): a multicentre, open-label, randomised trial

Mark D. Lyttle et al.

LANCET (2019)

Add to Collection

Article Clinical Neurology

Behavioral problems in children of mothers with epilepsy prenatally exposed to valproate, carbamazepine, lamotrigine, or levetiracetam monotherapy

Yfke Huber-Mollema et al.

EPILEPSIA (2019)

Add to Collection

Article Clinical Neurology

Synaptic vesicle protein 2A tumoral expression predicts levetiracetam adverse events

Michele Romoli et al.

JOURNAL OF NEUROLOGY (2019)

Add to Collection

Article Clinical Neurology

Effect of brivaracetam on the anger levels of epilepsy patients. A prospective open-labelled controlled study

Manuel Toledo et al.

SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2019)

Add to Collection

Review Behavioral Sciences

Seizure management and prescription patterns of anticonvulsants in Dravet syndrome: A multicenter cohort study from Germany and review of literature

Susanne Schubert-Bast et al.

EPILEPSY & BEHAVIOR (2019)

Add to Collection

Editorial Material Cardiac & Cardiovascular Systems

Levetiracetam and non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and epilepsy: a reasonable combination

Tim J. von Oertzen et al.

EUROPEAN HEART JOURNAL (2019)

Add to Collection

Article Medicine, General & Internal

Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus

Jaideep Kapur et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Add to Collection

Article Clinical Neurology

Clinical Use and Efficacy of Levetiracetam for Absence Epilepsies

Danielle Nolan et al.

JOURNAL OF CHILD NEUROLOGY (2019)

Add to Collection

Review Clinical Neurology

Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Role of Prophylactic Anticonvulsants in the Treatment of Adults with Metastatic Brain Tumors

Clark C. Chen et al.

NEUROSURGERY (2019)

Add to Collection

Article Medicine, General & Internal

Trends in antiepileptic drug treatment and effectiveness in clinical practice in England from 2003 to 2016: a retrospective cohort study using electronic medical records

Graham Powell et al.

BMJ OPEN (2019)

Add to Collection

Article Clinical Neurology

Use of Emergency Medication in Adult Patients with Epilepsy: A Multicentre Cohort Study from Germany

Jeannette Kadel et al.

CNS DRUGS (2018)

Add to Collection

Article Clinical Neurology

Use of brivaracetam in genetic generalized epilepsies and for acute, intravenous treatment of absence status epilepticus

Adam Strzelczyk et al.

EPILEPSIA (2018)

Add to Collection

Article Clinical Neurology

Clinical and electrographic features of sunflower syndrome

Fiona M. Baumer et al.

EPILEPSY RESEARCH (2018)

Add to Collection

Article Clinical Neurology

Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry

Torbjorn Tomson et al.

LANCET NEUROLOGY (2018)

Add to Collection

Article Multidisciplinary Sciences

Genetic (idiopathic) epilepsy with photosensitive seizures includes features of both focal and generalized seizures

Jiao Xue et al.

SCIENTIFIC REPORTS (2018)

Add to Collection

Review Clinical Neurology

Levetiracetam-Induced Seizure Aggravation in Patients With Focal Cortical Dysplasia

Emilija Cvetkovska et al.

CLINICAL NEUROPHARMACOLOGY (2018)

Add to Collection

Article Clinical Neurology

Genetic (idiopathic) generalized epilepsy with occipital semiology

Pablo Gomez-Porro et al.

EPILEPTIC DISORDERS (2018)

Add to Collection

Article Clinical Neurology

Guidelines for the Management of Severe Traumatic Brain Injury, Fourth Edition

Nancy Carney et al.

NEUROSURGERY (2017)

Add to Collection

Article Clinical Neurology

Resistance to valproic acid as predictor of treatment resistance in genetic generalized epilepsies

Joanna Gesche et al.

EPILEPSIA (2017)

Add to Collection

Article Behavioral Sciences

Psychiatric and behavioral side effects of antiepileptic drugs in adults with epilepsy

Baibing Chen et al.

EPILEPSY & BEHAVIOR (2017)

Add to Collection

Article Clinical Neurology

Brain tumor location influences the onset of acute psychiatric adverse events of levetiracetam therapy: an observational study

Vincenzo Belcastro et al.

JOURNAL OF NEUROLOGY (2017)

Add to Collection

Article Clinical Neurology

Myoclonic epilepsy in Down syndrome and Alzheimer disease

J. S. Aller-Alvarez et al.

NEUROLOGIA (2017)

Add to Collection

Article Clinical Neurology

Initial Treatment for Nonsyndromic Early-Life Epilepsy: An Unexpected Consensus

Renee A. Shellhaas et al.

PEDIATRIC NEUROLOGY (2017)

Add to Collection

Article Clinical Neurology

Newer Antiepileptic Drugs in Status Epilepticus: Prescription Trends and Outcomes in Comparison with Traditional Agents

Isabelle Beuchat et al.

CNS DRUGS (2017)

Add to Collection

Article Clinical Neurology

Incidence and Impact of Subclinical Epileptiform Activity in Alzheimer's Disease

Keith A. Vossel et al.

ANNALS OF NEUROLOGY (2016)

Add to Collection

Article Clinical Neurology

Dramatic effect of levetiracetam in early-onset epileptic encephalopathy due to STXBP1 mutation

Robertino Dilena et al.

BRAIN & DEVELOPMENT (2016)

Add to Collection

Review Neurosciences

Network abnormalities and interneuron dysfunction in Alzheimer disease

Jorge J. Palop et al.

NATURE REVIEWS NEUROSCIENCE (2016)

Add to Collection

Article Pediatrics

Paradoxical exacerbation of myoclonic-astatic seizures by levetiracetam in myoclonic astatic epilepsy

Yamane Makke et al.

BMC PEDIATRICS (2015)

Add to Collection

Editorial Material Clinical Neurology

Epileptic encephalopathies: Optimizing seizure control and developmental outcome

Lara Jehi et al.

EPILEPSIA (2015)

Add to Collection

Article Clinical Neurology

A randomized, double-blind comparison of antiepileptic drug treatment in the elderly with new-onset focal epilepsy

Konrad J. Werhahn et al.

EPILEPSIA (2015)

Add to Collection

Review Pediatrics

Antiepileptic drug treatment of rolandic epilepsy and Panayiotopoulos syndrome: clinical practice survey and clinical trial feasibility

Louise C. Mellish et al.

ARCHIVES OF DISEASE IN CHILDHOOD (2015)

Add to Collection

Article Clinical Neurology

Levetiracetam as alternative treatment in Jeavons syndrome

D. Parissis et al.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2014)

Add to Collection

Article Clinical Neurology

Genetic variation in dopaminergic activity is associated with the risk for psychiatric side effects of levetiracetam

Christoph Helmstaedter et al.

EPILEPSIA (2013)

Add to Collection

Review Neurosciences

Synaptic vesicle protein 2A: basic facts and role in synaptic function

Julieta Griselda Mendoza-Torreblanca et al.

EUROPEAN JOURNAL OF NEUROSCIENCE (2013)

Add to Collection

Article Clinical Neurology

KOMET: an unblinded, randomised, two parallel-group, stratified trial comparing the effectiveness of levetiracetam with controlled-release carbamazepine and extended-release sodium valproate as monotherapy in patients with newly diagnosed epilepsy

Eugen Trinka et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2013)

Add to Collection

Review Clinical Neurology

Neurobehavioral effects of levetiracetam in brain tumor related epilepsy

Abigail Bernett et al.

FRONTIERS IN NEUROLOGY (2013)

Add to Collection

Review Biochemistry & Molecular Biology

Mitochondrial toxicity of antiepileptic drugs and their tolerability in mitochondrial disorders

Josef Finsterer et al.

EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2012)

Add to Collection

Article Multidisciplinary Sciences

Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer's disease model

Pascal E. Sanchez et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)

Add to Collection

Article Clinical Neurology

Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association

E. Sander Connolly et al.

STROKE (2012)

Add to Collection

Article Clinical Neurology

A multicenter, randomized, placebo-controlled trial of levetiracetam in children and adolescents with newly diagnosed absence epilepsy

Cinzia Fattore et al.

EPILEPSIA (2011)

Add to Collection

Article Clinical Neurology

Synaptic vesicle protein 2A predicts response to levetiracetam in patients with glioma

M. de Groot et al.

NEUROLOGY (2011)

Add to Collection

Article Pharmacology & Pharmacy

Steady-State Pharmacokinetics of Intravenous Levetiracetam in Neurocritical Care Patients

Dustin D. Spencer et al.

PHARMACOTHERAPY (2011)

Add to Collection

Article Geriatrics & Gerontology

Treatment and Management of Epilepsy in the Elderly Demented Patient

Sigmund Jenssen et al.

AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS (2010)

Add to Collection

Review Behavioral Sciences

Benign epilepsy of childhood with centrotemporal spikes (BECTS): To treat or not to treat, that is the question

John R. Hughes

EPILEPSY & BEHAVIOR (2010)

Add to Collection

Article Clinical Neurology

Decreased expression of synaptic vesicle protein 2A, the binding site for levetiracetam, during epileptogenesis and chronic epilepsy

Erwin A. van Vliet et al.

EPILEPSIA (2009)

Add to Collection

Article Clinical Neurology

Expression patterns of synaptic vesicle protein 2A in focal cortical dysplasia and TSC-cortical tubers

Sjoukje T. Toering et al.

EPILEPSIA (2009)

Add to Collection

Article Clinical Neurology

A pilot trial of levetiracetam in eyelid myoclonia with absences (Jeavons syndrome)

Pasquale Striano et al.

EPILEPSIA (2008)

Add to Collection

Article Clinical Neurology

Levetiracetam for the treatment of idiopathic generalized epilepsy with myoclonic seizures

S. Noachtar et al.

NEUROLOGY (2008)

Add to Collection

Article Behavioral Sciences

Adjunctive therapy of uncontrolled partial seizures with levetiracetam in Australian patients

Ernest R. Somerville et al.

EPILEPSY & BEHAVIOR (2007)

Add to Collection

Article Clinical Neurology

Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy

M. J. Brodie et al.

NEUROLOGY (2007)

Add to Collection

Article Clinical Neurology

Levetiracetam in patients with generalised epilepsy and myoclonic seizures: An open label study

A Labate et al.

SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2006)

Add to Collection

Article Clinical Neurology

Antimyoclonic effect of levetiracetam in 13 patients with Unverricht-Lundborg disease: Clinical observations

A Magaudda et al.

EPILEPSIA (2004)

Add to Collection

Article Clinical Neurology

Discontinuation of levetiracetam because of behavioral side effects - A case-control study

JR White et al.

NEUROLOGY (2003)

Add to Collection

Article Pharmacology & Pharmacy

The anti-epileptic drug levetiracetam reverses the inhibition by negative allosteric modulators of neuronal GABA- and glycine-gated currents

JM Rigo et al.

BRITISH JOURNAL OF PHARMACOLOGY (2002)

Add to Collection

Article Clinical Neurology

Efficacy and tolerability of levetiracetam 3000 mg/d in patients with refractory partial seizures: A multicenter, double-blind, responder-selected study evaluating monotherapy

E Ben-Menachem et al.

EPILEPSIA (2000)

Add to Collection

Article Clinical Neurology

Levetiracetam for partial seizures - Results of a double-blind, randomized clinical trial

JJ Cereghino et al.

NEUROLOGY (2000)

Add to Collection

© Peeref 2019-2024. All rights reserved.